![](/img/cover-not-exists.png)
Long-term Intrathecal Morphine and Bupivacaine in Patients with Refractory Cancer Pain Results from a Morphine, Bupivacaine Dose Regimen of 0.5:4.75 mg/ml
Sjöberg, Magnus, Nitescu, Petre, Appelgren, Lennart, Curelaru, IoanVolume:
80
Journal:
Anesthesiology
DOI:
10.1097/00000542-199402000-00008
Date:
February, 1994
File:
PDF, 969 KB
1994